-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PM-534 in Hormone Sensitive Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PM-534 in Hormone Sensitive Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PM-534 in Hormone Sensitive Breast Cancer Drug Details: PM-534 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PM-534 in Castration-Resistant Prostate Cancer (CRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PM-534 in Castration-Resistant Prostate Cancer (CRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PM-534 in Castration-Resistant Prostate Cancer (CRPC) Drug Details: PM-534 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PM-1015 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PM-1015 in Solid Tumor Drug Details: PM-1015 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PM-534 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PM-534 in Solid Tumor Drug Details: PM-534 is under development for the treatment of advanced...
-
Product Insights
PMS 3 Solar PV Park
PMS 3 Solar PV Park is a solar PV project located in Grand Est, France. The project is owned by Pays de Montmedy Solaire 3 Sarl and was developed by Enerparc AG. The project came online in 2021. Empower your strategies with our PMS 3 Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
PMS 2 Solar PV Park
PMS 2 Solar PV Park is a solar PV project located in Grand Est, France. The project is owned by Pays de Montmedy Solaire 2 Sarl and was developed by Enerparc AG. The project came online in 2021. Empower your strategies with our PMS 2 Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
PMS 4 Solar PV Park
PMS 4 Solar PV Park is a solar PV project located in Grand Est, France. The project is owned by Pays de Montmedy Solaire 4 Sarl and was developed by Enerparc AG. The project came online in 2021. Empower your strategies with our PMS 4 Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
PMS 6 Solar PV Park
PMS 6 Solar PV Park is a solar PV project located in Grand Est, France. The project is owned by Pays de Montmedy Solaire 6 Sarl and was developed by Third Step Energy SAS. The project came online in 2021. Empower your strategies with our PMS 6 Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...
-
Product Insights
PMS 10 Solar PV Park
PMS 10 Solar PV Park is a solar PV project located in Grand Est, France. The project is owned by Pays de Montmedy Solaire 10 SAS and was developed by Third Step Energy SAS. The project came online in 2021. Empower your strategies with our PMS 10 Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...
-
Product Insights
PMS 7 Solar PV Park
PMS 7 Solar PV Park is a solar PV project located in Grand Est, France. The project is owned by Pays de Montmedy Solaire 7 Sarl and was developed by Third Step Energy SAS. The project came online in 2021. Empower your strategies with our PMS 7 Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...